Gregory Fraser
Stock Analyst at Truist Securities
(2.70)
# 2,175
Out of 5,105 analysts
39
Total ratings
57.14%
Success rate
16.91%
Average return
Main Sectors:
Stocks Rated by Gregory Fraser
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ANIP ANI Pharmaceuticals | Maintains: Hold | $77 → $90 | $80.39 | +11.95% | 11 | Oct 9, 2025 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | $200 → $205 | $167.50 | +22.39% | 2 | Aug 28, 2025 | |
| BHC Bausch Health Companies | Maintains: Hold | $8 → $7 | $6.92 | +1.16% | 2 | Jul 25, 2024 | |
| XAIR Beyond Air | Maintains: Buy | $200 → $160 | $1.06 | +14,994.34% | 6 | Apr 30, 2024 | |
| BTMD biote | Maintains: Buy | $10 → $9 | $2.70 | +233.33% | 2 | Jan 18, 2024 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $6 → $7 | $12.21 | -42.67% | 4 | Nov 8, 2023 | |
| CORT Corcept Therapeutics | Maintains: Hold | $26 → $29 | $87.99 | -67.04% | 5 | Aug 3, 2023 | |
| NVCR NovoCure | Reiterates: Buy | $95 | $13.33 | +612.95% | 3 | Jun 6, 2023 | |
| EOLS Evolus | Maintains: Buy | $14 → $18 | $7.04 | +155.68% | 2 | May 26, 2023 | |
| ARQT Arcutis Biotherapeutics | Maintains: Buy | $45 → $40 | $29.02 | +37.84% | 2 | May 26, 2023 |
ANI Pharmaceuticals
Oct 9, 2025
Maintains: Hold
Price Target: $77 → $90
Current: $80.39
Upside: +11.95%
Jazz Pharmaceuticals
Aug 28, 2025
Maintains: Buy
Price Target: $200 → $205
Current: $167.50
Upside: +22.39%
Bausch Health Companies
Jul 25, 2024
Maintains: Hold
Price Target: $8 → $7
Current: $6.92
Upside: +1.16%
Beyond Air
Apr 30, 2024
Maintains: Buy
Price Target: $200 → $160
Current: $1.06
Upside: +14,994.34%
biote
Jan 18, 2024
Maintains: Buy
Price Target: $10 → $9
Current: $2.70
Upside: +233.33%
Amneal Pharmaceuticals
Nov 8, 2023
Maintains: Buy
Price Target: $6 → $7
Current: $12.21
Upside: -42.67%
Corcept Therapeutics
Aug 3, 2023
Maintains: Hold
Price Target: $26 → $29
Current: $87.99
Upside: -67.04%
NovoCure
Jun 6, 2023
Reiterates: Buy
Price Target: $95
Current: $13.33
Upside: +612.95%
Evolus
May 26, 2023
Maintains: Buy
Price Target: $14 → $18
Current: $7.04
Upside: +155.68%
Arcutis Biotherapeutics
May 26, 2023
Maintains: Buy
Price Target: $45 → $40
Current: $29.02
Upside: +37.84%